Literature DB >> 7657279

Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis.

A Luca1, J C García-Pagán, J Bosch, F Feu, W Jiménez, A Ginés, M Fernández, A Escorsell, V Arroyo, J Rodés.   

Abstract

The study investigated the hemodynamic and neurohumoral effects of albumin infusion after total paracentesis in 18 patients with cirrhosis and tense ascites. Measurements of systemic and splanchnic hemodynamics, and vasoactive neurohumoral systems were performed before and immediately after total paracentesis. The patients were then randomized to receive albumin or not, and hemodynamic and humoral measurements were repeated at 24 hours. Hemodynamic and humoral changes just after paracentesis were similar in patients later randomized to receive albumin infusion or not. Twenty-four hours after total paracentesis, patients nor receiving albumin had total significant reductions in cardiac index (-13%; P = .005), femoral blood flow (-17%; P = .004), and pulmonary capillary pressure (-16%; P = .02), which were accompanied by significant increases in plasma renin activity (PRA) and plasma aldosterone (PA) and by significant decreases in atrial natriuretic factor (ANF) and plasma sodium. By contrast, there was no significant changes in patients receiving albumin, except for an increase in ANF and a further decrease in PA. In both groups, hepatic venous pressure gradient (HVPG) and azygos blood flow decreased just after paracentesis returning to baseline at 24 hours. This study shows that albumin infusion prevents the impairment in systemic hemodynamics, vasoactive neurohumoral systems, and plasma sodium after a large-volume paracentesis, without detrimental effects on portal pressure and portocollateral blood flow.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657279

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

1.  Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.

Authors:  G Nasr; A Hassan; S Ahmed; A Serwah
Journal:  J Cardiovasc Dis Res       Date:  2010-07

2.  Portal hemodynamics after large-volume paracentesis in patients with liver cirrhosis and tense ascites.

Authors:  S V Sagarad; Y K Chawla; R K Dhiman
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

3.  Beneficial effect of midodrine in hypotensive cirrhotic patients with refractory ascites.

Authors:  Achuthan Sourianarayanane; David S Barnes; Arthur J McCullough
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-02

4.  Management of the Cirrhotic Patient Before Liver Transplantation: The Role of the Referring Gastroenterologist.

Authors:  R Todd Stravitz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-05

5.  Reinfusion of concentrated ascitic fluid versus total paracentesis. A randomized prospective trial.

Authors:  A Graziotto; L Rossaro; P Inturri; M Salvagnini
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

6.  Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.

Authors:  R Moreau; T Asselah; B Condat; C de Kerguenec; F Pessione; B Bernard; T Poynard; M Binn; J D Grangé; D Valla; D Lebrec
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

Review 7.  Liver cirrhosis.

Authors:  E J Williams; J P Iredale
Journal:  Postgrad Med J       Date:  1998-04       Impact factor: 2.401

8.  Current position of vasoconstrictor and albumin infusion for type 1 hepatorenal syndrome.

Authors:  Abhasnee Sobhonslidsuk
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

9.  Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.

Authors:  Amine Benmassaoud; Suzanne C Freeman; Davide Roccarina; Maria Corina Plaz Torres; Alex J Sutton; Nicola J Cooper; Laura Iogna Prat; Maxine Cowlin; Elisabeth Jane Milne; Neil Hawkins; Brian R Davidson; Chavdar S Pavlov; Douglas Thorburn; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2020-01-16

Review 10.  Recent advances in the understanding and management of hepatorenal syndrome.

Authors:  Benedikt Simbrunner; Michael Trauner; Thomas Reiberger; Mattias Mandorfer
Journal:  Fac Rev       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.